|本期目录/Table of Contents|

[1]许双华,何庆,董作亮,等.肢端肥大症患者糖代谢异常和相关指标分析[J].天津医科大学学报,2021,27(02):133-136,194.
 XU Shuang-hua,HE Qing,DONG Zuo-liang,et al.Analysis of abnormal glucose metabolism and related indexes in patients with acromegaly[J].Journal of Tianjin Medical University,2021,27(02):133-136,194.
点击复制

肢端肥大症患者糖代谢异常和相关指标分析(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
27
期数:
2021年02期
页码:
133-136,194
栏目:
临床医学
出版日期:
2021-03-15

文章信息/Info

Title:
Analysis of abnormal glucose metabolism and related indexes in patients with acromegaly
文章编号:
1006-8147(2021)02-0133-05
作者:
许双华1何庆1董作亮2刘铭1
(天津医科大学总医院1.内分泌代谢科;2.医学检验科,天津300052)
Author(s):
XU Shuang-hua1 HE Qing1DONG Zuo-liang2 LIU Ming1
(1.Department of Endocrinology and Metabolism;2.Department of Medical Laboratory,General Hospital,Tianjin Medical University, Tianjin 300052,China)
关键词:
肢端肥大症糖尿病糖调节受损正常糖耐量生长激素胰岛素样生长因子-1
Keywords:
acromegalydiabetes mellitusimpaired glucose regulationnormal glucose toleranceGHIGF-1
分类号:
R584.1+1
DOI:
-
文献标志码:
A
摘要:
目的:评估肢端肥大症患者糖代谢异常及相关生化指标,探讨临床特点、生化指标和糖代谢的联系。方法:回顾性分析天津医科大学总医院内分泌代谢科51例初治肢端肥大症患者病历资料[女31例,男20例,平均年龄(49.51±12.07)岁],所有患者均接受75 g口服葡萄糖糖耐量试验(OGTT),根据血糖水平将患者分为正常糖代谢(NGT)组、糖调节受损(IGR)组以及糖尿病(DM)组,比较3组患者的临床特点及生化指标,计算稳态模型评估-胰岛素抵抗指数(HOMA-IR)及稳态模型评估-胰岛β细胞功能指数(HOMA-β),分析年龄、家族史、生长激素(GH)、胰岛素样生长因子-1(IGF-1)与血糖(Glu)、HOMA-IR、HOMA-β、血糖处置指数(DI)和松田指数(MI)的相关性,并通过Logistic回归分析肢端肥大症患者发生糖尿病的相关危险因素。结果:NGT组14例,占27.4%,IGR组13例,占25.4%,DM组24例,占47.1%。DM组年龄高于NGT组、IGR组,但差异均无统计学意义。DM组糖化血红蛋白(HbA1c)水平高于IGR组、NGT组(F=8.12,P=0.000),且DM组胰岛素抵抗最严重。与IGR组、NGT组相比,DM组HOMA-β、30 min血糖处置指数(DI30)、120 min血糖处置指数(DI120)、松田指数(MI)和早期胰岛素分泌(AUC Ins 30/AUC Glu 30)、总胰岛素分泌(AUC Ins 120/AUC Glu 120)较NGT组、 IGR组均明显下降(F=21.12、50.50、55.53、5.54、13.52、15.77,均P<0.05);3组之间GH、IGF-1差异无统计学意义(F=2.27、2.12,均P>0.05)。3组OGTT后0、30、60、120、180 min Glu差异有统计学意义,在30、60、120 min胰岛素差异有统计学意义,而在各个时间点GH水平均无统计学差异;GH、IGF-1水平与HOMA-β以及HOMA-IR未见相关性;年龄与HOMA-β呈负相关(r=-0.560,P=0.000),与OGTT 120 min Glu呈正相关(r=0.340,P=0.013)。Logistic回归分析显示,糖尿病家族史比无家族史OGTT 120 min 血糖水平高(β=4.76,P=0.032)。结论:年龄和糖尿病家族史是肢端肥大症发生糖代谢紊乱的危险因素。GH和IGF-1水平与糖代谢紊乱没有相关性。
Abstract:
Objective: To evaluate the abnormal glucose metabolism and related biochemical indexes in patients with acromegaly, and to discuss the relationship between clinical characteristics, biochemical indexes and glucose metabolism. Methods: Fifty-one patients with acromegaly[31 women,20 men,mean age(49.51±12.07)years old] were analyzed regressively in the Department of Endocrine and Metabolism, General Hospital,Tianjin Medical University. All patients underwent an oral 75 g of glucose tolerance test (OGTT). According to the blood glucose level,the patients were divided into normal glucose metabolism group(NGT group), impaired glucose regulation group(IGR group) and diabetic group(DM group),and the clinical characteristics and biochemical indexes among the three groups were compared. Then homeostasis model assessment of insulin resistance(HOMA-IR) and homeostasis model assessment of β-cell function(HOMA-β)were calculated,and the correlation between age,family history,GH,IGF-1 and blood glucose,HOMA-IR,HOMA-β,blood glucose esposition index(DI), Matsuda index(MI)were analyzed. The related risk factors of diabetes in patients with acromegaly were analyed by Logistic regression analysis. Results: There were 14 people(27.4%)in NGT group,13(25.4%)in IGR group, and 24(47.1%) in DM group, respectively .The age of DM group was higher than that of NGT group and IGR group, but the difference was not statistically significant.The HbA1c of DM group was higher than that in IGR group and NGT group(F=8.12,P=0.000), and the insulin resistance in DM group was the most serious.The HOMA-β, DI at 30 minutes(DI30),DI at 120 minutes(DI120),MI, islet secretion index AUC Ins 30/AUC Glu 30 and AUC Ins 120/AUC Glu 120 in DM group were significantly lower than those in IGR group and NGT group(F=21.12,50.50, 55.53,5.54,13.52,15.77,all P <0.05), however the level of GH and IGF-I was not significant difference among the three groups(F=2.27,2.12,P>0.05).There were significant differences in blood glucose at 0,30,60,120 and 180 min and in insulin at 30,60 and 120 min after OGTT among the three groups, but there was no significant difference in GH level at each time point.The level of GH and IGF-1 were not correlated with HOMA-β and HOMA-IR. Age was negatively correlated with HOMA-β(r=-0.560,P =0.000),and positively correlated with OGTT 120 min blood glucose(r =0.345,P=0.013). Linear regression analysis showed that the OGTT 120 min blood glucose level in the patients who have the family history of diabetes was higher than that of withowt family history(β=4.76,P=0.032). Conclusion: Age and family history of diabetes are the risk factors of secondary diabetes in acromegaly. On the contrary, there is not significant correlation between the levels of GH or IGF-1 and the disorder of glucose metabolism.

参考文献/References:

[1] Moller N,Jorgensen J O. Effects of growth hormone on glucose, lipid,and protein metabolism in human subjects[J]. Endocr Rev, 2009,30(2):152
[2] Vila G, J?覬rgensen J, Luger A,et al. Insulin resistance in patients with acromegaly[J]. Front Endocrinol (Lausanne),2019,10:509
[3] Puder J J,Nilavar S,Post K D,et al. Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly[J]. J Clin Endocrinol Metab,2005,90(4):1972
[4] 张燕,李平,张文婧,等. 肢端肥大症合并糖代谢异常的临床特征及其影响因素[J]. 中华内分泌代谢杂志,2019,35(3):206
[5] 雷霆,徐钰,陈娟. 加强多学科协作,努力提高肢端肥大症诊治水平——《中国肢端肥大症诊治指南(2013版)》解读[J]. 中国神经肿瘤杂志,2013,11(4):226
[6] Colao A,Ferone D,Marzullo P,et al. Systemic complications of acromegaly:epidemiology,pathogenesis,and management[J]. Endocr Rev,2004,25(1):102
[7] Espinosa-de-los-Monteros A L,González B,Vargas G,et al. Clinical and biochemical characteristics of acromegalic patients with different abnormalities in glucose metabolism[J]. Pituitary,2011,14(3): 231
[8] Fieffe S,Morange I,Petrossians P,et al. Diabetes in acromegaly,prevalence,risk factors,and evolution: data from the French Acromegaly Registry[J]. Eur J Endocrinol,2011,164(6):877
[9] Biering H,Knappe G,Gerl H,et al. Prevalence of diabetes in acromegaly and Cushing syndrome[J]. Acta Med Austriaca,2000, 27(1):27
[10] Ciresi A,Amato M C,Pivonello R,et al. The metabolic profile in active acromegaly is gender-specific[J]. J Clin Endocrinol Metab,2013,98(1):E51
[11] Ferraù F,Albani A,Ciresi A,et al. Diabetes secondary to acromegaly: physiopathology,clinical features and effects of treatment[J]. Front Endocrinol(Lausanne),2018,9:358
[12] Kreze1 A,Kreze-Spirova1 E,Mikulecky M. Risk factors for glucose intolerance in active acromegaly[J]. Braz J Med Biol Res,2001,34:1429
[13] Alexopoulou O,Bex M,Kamenicky P,et al. Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients[J]. Pituitary,2014,17(1):81
[14] Clemmons D R. Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly[J]. Pituitary,2002,5(3):181
[15] Yakar S,Liu J L,Fernandez A M,et al. Liver-specific IGF-1 gene deletion leads to muscle insulin insensitivity[J]. Diabetes,2001,50(5):1110
[16] Yuka K,Hiroko F,Akira T,et al. Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic {beta}-cell function is preserved[J]. Eur J Endocrinol,2011,164(4):467
[17] Cheng S,Al-Agha R,Araujo P B,et al. Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly[J]. PLoS One,2013,8(9):e73543

相似文献/References:

[1]王树峰,杨 丽,刘 寅.脂蛋白相关磷脂酶A2与冠心病和2型糖尿病的关系[J].天津医科大学学报,2013,19(06):456.
 WANG Shu-feng,YANG Li,LIU Yin.Relationship between lipoprotein-associated phospholipase A2 and coronary heart disease as well as type 2 diabetes mellitus[J].Journal of Tianjin Medical University,2013,19(02):456.
[2]苏东峰,聂秀玲,孙丽荣.2型糖尿病合并高尿酸血症临床特征及相关危险因素分析[J].天津医科大学学报,2013,19(06):481.
[3]武 鑫,李明珍,孙丽荣.2型糖尿病患者血清γ-谷氨酰转移酶与胰岛β细胞功能的关系[J].天津医科大学学报,2014,20(02):147.
 WU Xin,LI Ming-zhen,SUN Li-rong.Association of serum gamma-glutamyltransferase with islet β cell function in type 2 diabetic patients[J].Journal of Tianjin Medical University,2014,20(02):147.
[4]刘 芳,李明珍,孙丽荣.住院2型糖尿病患者睡眠质量与血糖及并发症的关系[J].天津医科大学学报,2014,20(03):213.
 LIU Fang,LI Ming-zhen,SUN Li-rong.Relationship between sleep quality and glucose level as well as diabetic complications in hospital patients with type 2 diabetes mellitus[J].Journal of Tianjin Medical University,2014,20(02):213.
[5]李凤英,朱铁虹.中年男性2型糖尿病患者促甲状腺激素与尿钙/肌酐比值的相关性研究[J].天津医科大学学报,2014,20(05):389.
 LI Feng-ying,ZHU Tie-hong.Relationship between thyroid stimulating hormone and urinary calcium/creatinine excretion in middle-aged man with type 2 diabetes[J].Journal of Tianjin Medical University,2014,20(02):389.
[6]谭艳萍,吴校伟,刘 寅,等. 冠心病合并糖尿病患者药物涂层支架术后观察[J].天津医科大学学报,2014,20(05):414.
[7]陈河清,郭秀梅,金力里.2型糖尿病患者牙周病与糖尿病肾病的相关性分析[J].天津医科大学学报,2014,20(06):469.
 CHEN He-qing,GUO Xiu-mei,JIN Li-li. Correlation between diabetic nephropathy and periodontal disease[J].Journal of Tianjin Medical University,2014,20(02):469.
[8]马 静,赵立华,谢 云.血浆纤维蛋白原与糖尿病肾病的相关性研究[J].天津医科大学学报,2015,21(03):60.
 Ma Jing,ZHAO Li-hua,XIE Yun.Relationship between plasma fibrinogen concentration and diabetic nephropathy [J].Journal of Tianjin Medical University,2015,21(02):60.
[9]马 静,赵立华,谢 云. 血浆纤维蛋白原与糖尿病肾病的相关性研究[J].天津医科大学学报,2015,21(01):60.
 MA Jing,ZHAO Li-hua,XIE Yun.Relationship between plasma fibrinogen concentration and diabetic nephropathy[J].Journal of Tianjin Medical University,2015,21(02):60.
[10]李 冰,冯 凭.罗格列酮干预糖尿病大鼠脂肪组织CMKLR1及Chemerin基因表达[J].天津医科大学学报,2015,21(06):484.
 LI Bing,FENG Ping.Effect of rosiglitazone on the expression of CMKLR1 and Chemerin mRNA in the adipose tissue of diabetic rat[J].Journal of Tianjin Medical University,2015,21(02):484.

备注/Memo

备注/Memo:
作者简介 许双华(1995-),女,硕士在读,研究方向:肢端肥大症的糖代谢异常;通信作者:何庆,E-mail:hech69@hotmail.com。
更新日期/Last Update: 2021-03-10